16. Hirsh J, Levine MN. Low molecular weight heparin. Blood 1992;79:1-17.
17. Hirsh J, Warkentin TE, Raschke R, et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics,
dosing considerations, monitoring, efficacy, and safety. Chest 1998;114 (5 suppl):489S-510S. [Erratum in: Chest 1999;115:1760.]
18. Hopper K, Bateman S. An updated view of hemostasis: mechanisms of hemostatic dysfunction associated with sepsis. J Vet Emerg Crit Care 2005;15:83-91.
19. Good LI, Manning AM. Thromboembolic disease: physiology of hemostasis and pathophysiology of thrombosis. Compend Contin Educ Pract Vet 2003;25:650-659.
20. Roncales FJ, Sancho JM. Coagulation activators. In: Feldman BF, Zinkl JG, Jain NC, eds. Schalm's veterinary hematology. 5th ed. Philadelphia, Pa: Lippincott, Williams & Wilkins, 2000;532-537.
21. Luchtman-Jones L, Broze GJ Jr. The current status of coagulation. Ann Med 1995;27:47-52.
22. Di Nisio M, Middeldorp S, Buller HR. Direct thrombin inhibitors. N Engl J Med 2005;353:1028-1040. [Erratum in: N Engl J Med 2005;353:2827.]
23. Johnstone IB. Coagulation inhibitors. In: Feldman BF, Zinkl JG, Jain NC, eds. Schalm's veterinary hematology. 5th ed. Philadelphia, Pa: Lippincott, Williams, & Wilkins, 2000;538-542.
24. Darien BJ. Acquired coagulopathy V: thrombosis. In: Feldman BF, Zinkl JG, Jain NC, eds. Schalm's veterinary hematology. 5th ed. Philadelphia, Pa: Lippincott, Williams & Wilkins, 2000;574-580.
25. McNicol PL, Liu G, Harley ID, et al. Patterns of coagulopathy during liver transplantation: experience with the first 75
cases using thromboelastography. Anaest Intensive Care 1994;22:659-665.
26. Allwood AJ, Downend AB, Slensky KA, et al. Evaluation of thromboelastography (TEG) in normal cats (abst.). J Vet Emerg Crit Care 2004;14:S1.
27. Verstraete M. Heparin and thrombosis: a seventy year long story. Haemostasis 1990;20 (suppl 1):4-11.
28. Harenberg J. Pharmacology of low molecular weight heparins. Semin Thromb Hemost 1990;16 Suppl:12-18.
29. Breuhl EL, Scott-Moncrief C, Brooks MB. A prospective study of unfractionated heparin therapy to prevent thrombosis in canine
immune-mediated hemolytic anemia (abst). J Vet Intern Med 2005;19:399-400.
30. Fryer JS, McMichael MA, Slater MR. Effect of heparin use on survival to discharge of dogs with immune mediated hemolytic
anemia (abst). J Vet Intern Med 2005;19:400.
31. Braz-Ruivo L. Thromboembolic disease in cats. In: Mathews KA. Veterinary emergency and critical care manual. Guelph, Ontario: Lifelearn, 2006;194-197.
32. Mischke RH, Schuttert C, Grebe SI. Anticoagulant effects of repeated subcutaneous injections of high doses of unfractionated
heparin in healthy dogs. Am J Vet Res 2001;62:1887-1891.
|
Featuring Information from:
